Amblyopia: Clinical Guidelines

Applies tochildren2026 editionH53.0

Clinical Guidelines of the Russian Ministry of Health, pediatric. 2026 edition, ICD-10 codes: H53.0.

Get research articles on the topic of "Amblyopia"Every morning — fresh PubMed studies on this topic and specialty: in Russian, with figures, sample sizes, and conclusions. Plus updates on changes in Russian clinical guidelines.

Subscribe for 990 ₽

Brief for Practice

WhiteCoat Pro editorial summary of the guideline text, 2026 edition. Each point links to the original section — verify with it before prescribing.

Amblyopia is a functional reduction of mono- or binocular vision without visible organic pathology of the visual pathway, arising from restricted visual experience during the development of the visual system. These recommendations focus on the diagnosis, optical correction, pleoptic treatment, and monitoring primarily of children; key aspects include timely detection of ametropia, exclusion of structural pathology, and assessment of fixation.

Key points

Diagnostics

  1. In case of decreased vision or suspected amblyopia, the child is referred for an initial ophthalmological examination; concomitant functional disorders are also assessed and management tactics are determined (Level of Evidence C, Grade of Recommendation 5). → in text
  2. Complaints of decreased distance and near vision, focusing difficulties, visual fatigue, and headaches are clarified; the age of onset, previous correction, its tolerability and usage regimen, as well as prior treatment, are ascertained (Level of Evidence C, Grade of Recommendation 5). → in text
  3. Visual acuity is measured without correction, with existing glasses or contact lenses, and with optimal correction; the degree of amblyopia is assessed based on the best-corrected visual acuity (Level of Evidence C, Grade of Recommendation 5). → in text
  4. Refraction is determined under non-cycloplegic conditions and subsequently under cycloplegia; if autorefractometry is impossible or unreliable, skiascopy is used (Level of Evidence C, Grade of Recommendation 5). For cycloplegia in children aged 3 years and older, 1% cyclopentolate is instilled as 1 drop 2–3 times at 15–20 minute intervals into each conjunctival sac (Level of Evidence A, Grade of Recommendation 1). → in text
  5. Eye position, angle of strabismus, ocular motility, convergence, type of vision, and heterophoria are examined to determine the strabismic component and other functional disorders (Level of Evidence C, Grade of Recommendation 5). → in text
  6. Biomicroscopy is performed to rule out other causes of decreased visual acuity, ophthalmoscopy under mydriasis to exclude pathological changes of the retina and optic nerve, and optical imaging of the posterior segment of the eye to identify or rule out structural anomalies of the posterior pole (Level of Evidence C, Grade of Recommendation 5). → in text
  7. In high and very high degrees, fixation is assessed ophthalmoscopically and/or microperimetrically (Level of Evidence B, Grade of Recommendation 3); eccentric fixation is defined when the fixation point is displaced from the foveolar center by more than 2°, and unstable central fixation if less than 75% of points fall within the 2° area. → in text

Treatment

When to refer and how to monitor

Frequently asked questions

What criterion confirms the diagnosis of amblyopia?

Best-corrected visual acuity of 0.7 and below in the absence of structural abnormalities of the visual pathway. Structural abnormalities rule out the diagnosis of amblyopia. → in text

What instrumental examinations are recommended when amblyopia is suspected?

Visometry without correction, with existing and optimal correction, refractometry, assessment of eye position and binocular interaction, biomicroscopy, and ophthalmoscopy are recommended. In high and very high degrees, fixation is additionally assessed. → in text

How is cycloplegia performed in a child with amblyopia?

From the age of 3 years, 1% cyclopentolate is used: 1 drop 2–3 times in each conjunctival sac at 15–20 minute intervals (Level of Evidence A, Grade of Recommendation 1). In special cases in children aged 7 years and older, 1% atropine is applied twice daily for 3 days. → in text

How is concomitant ametropia corrected in amblyopia?

Spectacle and/or contact lens correction is selected to compensate for refractive and functional disorders. → in text

What functional treatment methods are used for amblyopia?

To improve visual acuity, pleoptic treatment is used, including occlusion or penalization and retinal stimulation methods. → in text

When is microperimetric biofeedback indicated?

The method is used from the age of 5 years in cases of eccentric or unstable central fixation. The course includes training sessions of 10–12 minutes 3 times a week, for a total of 12–18 sessions (Level of Evidence B, Grade of Recommendation 3). → in text

Status
Applied · approved by the Scientific and Practical Council of the Russian Ministry of Health
Database ID
1063, edition 1 (ID 1063_1)
Publication date
July 30, 2026
Age category
children
ICD-10 codes
H53.0
Specialties
OphthalmologyPediatrics
Developers
All-Russian Public Organization "Association of Ophthalmologists"
Official text
Ministry of Health Guidelines Rubricator — 1063_1

List of Abbreviations

BF – Biofeedback

D – diopter

VEP – visual evoked potentials

BCVA – best-corrected visual acuity

MP – microperimetry

M-BFB – microperimetric biofeedback

RLS – register of medicines

CNS – central nervous system

cpd – cycles per degree

ERG – electroretinography

EP – electrophysiological studies

BCEA – bivariate contour ellipse area

PRL – preferred retinal locus

TRL – training retinal locus

Terms and Definitions

Amblyopia is a symptom complex characterized primarily by mono- or binocular reduction of visual functions without visible organic lesions of the visual pathway, which developed as a result of restricted sensory experience (deprivation) during the development of the visual system.

Binocular vision – the integrated activity of the sensory and motor systems of both eyes, ensuring the simultaneous orientation of visual axes toward the fixation object, the fusion of monocular images of this object into a single visual percept, and its localization in the corresponding spatial location.

Biofeedback is a treatment and rehabilitation method based on developing a patient's self-control and self-regulation skills for various bodily functions to improve overall health.

Diploptics is a method for treating strabismus based on eliminating the phenomenon of visual suppression of the squinting eye's image under natural conditions by inducing diplopia and developing the fusion reflex of bifixation.

Visual fixation is a relatively immobile positioning of the gaze on the object being viewed.

Orthoptic treatment is a functional treatment method aimed at restoring the symmetrical position of the eyes.

Microperimetry is the combined use of computer perimetry and fundus biomicrophotography using a fundus camera.

Pleoptic treatment (pleoptic therapy) is a system of treatment methods aimed at improving visual acuity in amblyopia.

Concomitant strabismus is a form of oculomotor and visual impairment characterized by the deviation of the eye from the common fixation point, leading to impaired binocular vision. In concomitant strabismus, the functions of individual muscles are not impaired.

1. Brief information on the disease or condition

1.1 Definition of the disease or condition

Amblyopia is a symptom complex characterized by mono- or binocular reduction of visual functions without visible organic lesions of the visual pathway, which developed as a result of sensory experience restriction during the development of the visual system [1,2,3,4,5].

1.2 Etiology and pathogenesis of the disease or condition (group of diseases or conditions)

In amblyopia, there are no organic changes, and its main causes are visual deprivation (refractive/deprivation amblyopia) and/or abnormal binocular interaction (strabismic/anisometropic amblyopia) [1,2,3,4,5,6].

The physiological mechanisms of binocular vision are based on the classical theory of retinal correspondence, according to which binocular vision is a sensory-motor apparatus organized on the principle of a reflex arc. In strabismic amblyopia, the sensory-motor mechanism that implements the transfer from disparate (non-corresponding) retinal points to corresponding ones—the bifixation mechanism—is disrupted. Confusion arises in the binocular center, i.e., the superposition of two different images. To eliminate confusion, a functional suppression scotoma is formed, which shuts down the retino-cortical pathway of the squinting eye, leading to a persistent decrease in vision and the development of amblyopia [1,2,7,8,9]. The second stage involves the formation of eccentric fixation: when the leading eye is covered, the amblyopic eye positions itself such that the image of the fixated object is projected onto a non-central area of the retina with better visual acuity than at the center—within the zone where the suppression scotoma forms. According to various authors, strabismic amblyopia is frequently complicated by incorrect fixation [1,3,4,10].

The cause of refractive amblyopia is the absence of a clear image on the retina and, consequently, of normal sensory experience during the development of the visual system. In 33–98.4% of children with refractive errors, particularly with astigmatism, refractive amblyopia is observed due to the late prescription of appropriate correction [1,3,4,6].

The cause of anisometropic amblyopia is aniseikonia—differing image sizes on the retinas of both eyes, which prevents the fusion of two images into a single visual percept [1,2,3]. At high degrees of anisometropia (above 5.0–6.0 D), the visual system of the worse eye severely lags in development, which can lead to the deviation of the eye from the visual axis and the occurrence of mixed-origin amblyopia [1].

The cause of obscuration amblyopia can be complete or partial opacification of the optical media (cornea, lens, vitreous body), developmental anomalies (lenticonus, lens coloboma, congenital aphakia, ptosis), leading to limited visual experience and typically high and very high degrees of amblyopia, which may persist even after surgical removal of the obscuration (deprivation) [1,5,11,12].

The role of hysteria in functional visual disorders is well known and widely recognized. Psychogenic factors can be the cause of hysterical amblyopia. Even with a thorough ophthalmological examination, this type of amblyopia is difficult to detect. It is observed in 1.5–1.75% of children with amblyopia [2,4,5,13].

1.3 Epidemiology of the Disease or Condition

Amblyopia is the most common cause of monocular visual acuity loss in children, with its prevalence ranging from 0.05% to 7.54% according to various studies [14,15,16,17,18,19,20,21,22]. In Russia, according to federal statistical reporting forms for 2011–2017, more than 1 million children suffer from visual impairments: myopia, hyperopia, astigmatism, amblyopia, and strabismus [23,24,25]. Ametropias account for up to 6% of the structure of visual disability, and visually impaired individuals from childhood make up 20.7% of the total number of disabled people in Russia [14,15,23]. Amblyopia is observed in 52.4% of patients with divergent strabismus and in 69.6% of patients with convergent strabismus. High and very high degree strabismic amblyopia is frequently complicated by incorrect fixation [1,3,4,10,26].

1.4 Features of Coding the Disease or Condition

H53.0 – Amblyopia

1.5 Classification of the disease or condition

The clinical classification by E.S. Avetisov, based on the causes of vision reduction in this pathology, visual acuity assessment, and the state of fixation [1].

According to the degree of visual acuity reduction, amblyopia is classified as:

▪ mild – with a visual acuity of 0.4–0.8;

▪ moderate – with a visual acuity of 0.2–0.3;

▪ severe – with a visual acuity of 0.05–0.1;

▪ very severe – with a visual acuity of 0.04 and below.

According to the mechanism of development, amblyopia is classified as:

▪ strabismic (arising due to impaired binocular vision);

▪ refractive (in the presence of refractive errors and untimely or inconsistent wearing of optical correction);

▪ anisometropic (difference in refraction between the eyes);

▪ obscuration (due to opacities of the ocular media — congenital cataract, corneal leucoma, etc.);

▪ hysterical;

▪ relative (in nystagmus, congenital myopia).

According to the state of visual fixation, the following are distinguished:

▪ stable central fixation (foveal);

▪ stable and unstable non-central fixation (parafoveal, macular, paramacular, and peripheral);

▪ absence of visual fixation.

1.6 Clinical presentation of the disease or condition

Patient complaints include deterioration of distance and near visual acuity, visual fatigue, and headaches associated with visual load. Patients frequently complain of constant or periodic strabismus.

Examination of visual acuity reveals a decrease in both uncorrected and corrected visual acuity. In cases of high and very high degree amblyopia, non-central fixation in the amblyopic eye is frequently diagnosed. Objective refraction testing typically reveals abnormalities.

Many patients with amblyopia are diagnosed with impaired binocular functions: monocular vision, simultaneous vision, functional scotoma.

The anterior segment is generally unremarkable. No pathology is detected in the fundus.

2. Diagnostics, medical indications and contraindications for diagnostic methods

Criteria for establishing the diagnosis of "amblyopia": best-corrected visual acuity (BCVA) values of 0.7 and below without structural abnormalities of the visual pathway [1].

It is recommended to perform an initial consultation (examination, evaluation) by an ophthalmologist (B01.029.001) in children with signs of decreased vision and/or suspected amblyopia for the purpose of diagnosing amblyopia, concomitant functional disorders, and determining patient management tactics [1,3,4,9].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to perform a follow-up consultation (examination, evaluation) by an ophthalmologist (B01.029.002) in children with amblyopia for the purpose of assessing the dynamics of the functional state of the eyes and determining further patient management tactics [1,3,4,9].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to perform an initial consultation (examination, evaluation) by a neurologist (B01.023.001) and a follow-up consultation (examination, evaluation) by a neurologist (B01.023.002) in children with amblyopia to identify concomitant central nervous system functional disorders, manage them, and determine the feasibility of functional treatment [1,4,27,28,29].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to perform an initial consultation (examination, evaluation) by a psychotherapist (B01.034.001) and a follow-up consultation (examination, evaluation) by a psychotherapist (B01.034.002) in children with hysterical amblyopia to identify signs of neurotic disorder, determine its causes, and alleviate symptoms [1,13,29,30].

GRC CLEL 4Grade of Recommendation C (Level of Evidence – 4)

2.1 Complaints and Anamnesis

It is recommended, when collecting anamnesis and complaints in ocular pathology (A01.26.001), to evaluate complaints of decreased distance and near visual acuity, focusing difficulties, visual fatigue, and headaches associated with visual load in children starting from the age when the child is able to formulate complaints, in order to assess the degree of impact of amblyopia on visual functions and quality of life [1,3,4,9,29].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended when taking the medical history and complaints in eye pathology (A01.26.001) to pay special attention to the age at which amblyopia was first detected, existing correction, satisfaction with the correction and its tolerability, the mode of use of the correction, and previously performed functional treatment in children with amblyopia in order to assess the dynamics of the condition, compliance of the previously prescribed treatment with the condition, treatment efficacy, and prognosis [1,3,4,9,29].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

Comments: when assessing the medical history of the disease, special attention should be paid to the age at which optical correction was first prescribed and the time of the latest correction prescription. Evaluation of the existing correction should be performed using a lensmeter. Assessment of refraction dynamics should be based on previous examination data or previously prescribed corrective glasses. Assessing refraction dynamics based on the patient's words is of low информативность. When assessing the personal history, special attention should be paid to the features and conditions of the patient's visual activity, compliance with the pleoptic treatment regimen, and prior orthoptic-pleoptic treatment [1,3,4,9].

2.2 Physical Examination

Physical examination is not performed for amblyopia.

2.3 Laboratory Diagnostics

Laboratory diagnostic tests are not performed for amblyopia.

2.4 Instrumental Diagnostics

It is recommended to perform visual acuity testing (A02.26.004) without correction in children with amblyopia, starting from the age when the child is able to name optotypes, in order to assess the severity of visual acuity impairment due to amblyopia [1,3,4,9,29,31,32,33,34].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to perform visual acuity testing (A02.26.004) in existing glasses or contact lenses in children with amblyopia, starting from the age when the child is able to name optotypes, in order to assess and monitor the effect of the existing correction on visual acuity [1,2,3,4,9,29,31,32,33,34].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to perform visual acuity testing (A02.26.004) with optimal correction in children with amblyopia, starting from the age when the child is able to name optotypes, in order to determine the maximum corrected visual acuity, assess the degree of amblyopia, and monitor the condition [29,31,32,33,34].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

Comments: visual acuity testing in children under three years of age is performed tentatively – it is determined whether the child has object vision. More precise measurement is possible using the preferential looking test and the visual evoked cortical potentials recording method [29,32]. Visual acuity testing in children aged three years and older is performed: from 3 years of age using children's silhouette pictures [32], and from 5 years of age using Landolt rings or "E" tests [29].

It is recommended to perform refractometry (A03.26.008) under natural conditions by determining refraction using a trial lens set (A02.26.013), unmydriatic autorefractometry (A12.26.016), and/or skiascopy (A02.26.014) in order to assess dynamic ocular refraction and identify ametropias comorbid with amblyopia [29,31,33,34,35,36,37].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to perform refractometry (A03.26.008) under conditions of cycloplegia using autorefractometry, skiascopy (A02.26.014), and/or subjective refraction determination using a trial lens set (A02.26.013) in children with amblyopia in order to assess static refraction, diagnose ametropias comorbid with amblyopia, and prescribe appropriate correction [29,31,33,34,35,36,37].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

Comments: automatic refractometry and keratorefractometry is a reliable method for diagnosing refractive errors. The method allows for rapid and accurate refraction testing in children older than three years under both narrow and wide pupil conditions. In children older than one year, the examination is possible using a handheld modification of the autorefractometer [35], and in children under 1 year of age, a pediatric remote autorefractometer can be used [36].

It is recommended to use skiascopy (retinoscopy) (A02.26.014) when autorefractometry is impossible or yields incorrect results due to age or other reasons in children with amblyopia in order to objectively assess refraction [4,33,37].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to instill medicinal products into the conjunctival sac (A14.26.002) — eye drops of cyclopentolate 1% 1 drop 2–3 times at intervals of 15–20 minutes into each conjunctival sac as an anticholinergic agent in children with amblyopia from the age of three in order to achieve sufficient cycloplegia for refraction determination [38,39,40].

GCR ALEL 1Grade of Recommendations A (Level of Evidence – 1)

It is recommended to instill medicinal products into the conjunctival sac (A14.26.002) — atropine 1%** in children with amblyopia starting from 7 years of age, 2 times a day for 3 days, in order to determine true ocular refraction and examine the fundus in special cases [4,29,39,40].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to examine existing glasses using a lensmeter or by the neutralization method in children with amblyopia in order to determine the refraction of spectacle lenses and their compliance with the prescription and/or the patient's refraction [31,34].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to determine eye position by measuring the angle of strabismus (A02.26.010) using Hirschberg's test and/or a synoptophore and/or prisms in children with amblyopia in order to identify the dysbinocular nature of amblyopia and determine further treatment tactics [1,3,4,7,9,33].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to examine eye motility (A02.26.028) and convergence (A02.26.026) in children with amblyopia of any genesis in order to determine the type of amblyopia, its effect on oculomotor functions, and further treatment tactics [1,3,4,7,9,33].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

Comments: in amblyopia combined with concomitant strabismus, the mobility of the eyeballs is fully preserved. In amblyopia combined with incomitant strabismus, there is a restriction of eyeball mobility (depending on the affected extraocular muscle).

It is recommended to examine binocular interaction — determine the character of vision and heterophoria (A02.26.024) in children with amblyopia, starting from the age when the child is able to perform tests, in order to determine the causes of amblyopia development, the severity of functional disorders comorbid with amblyopia, and further treatment tactics [1,3,4,7,9,33].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to perform ophthalmoscopy (A02.26.003) with assessment of visual fixation in children with high and very high degrees of amblyopia in order to evaluate the type of fixation and determine further treatment tactics [1,3,4,10,26,33,41,42,43,44].

GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)

Comments: fixation is examined using a monobinoscope, ophthalmoscope, and/or microperimeter.

It is recommended to perform optical examination of the retina using a computer analyzer (A03.26.019) via microperimetry in children with high and very high degrees of amblyopia in order to assess fixation, its type, stability, area, and density, and to determine further treatment tactics and prognosis [41,42].

GCR BLoE 3Level of Evidence B (Level of Confidence of Evidence – 3)

Assessment of fixation stability using a microperimeter is carried out under mesopic conditions, monocularly, without mydriasis. Before the examination, patients are instructed and undergo trial testing. A 2° red cross is used as a fixation target during the examination. The patient is asked to fixate on the center of the red cross for 30 seconds. During the examination, the preferred locus of fixation is determined automatically and displayed at the end of the examination as a red cross on the fundus image. Fixation stability is evaluated quantitatively by measuring the area of two-dimensional contour ellipses (BCEA°2) encompassing 68%, 95%, and 99% of the fixation points. A smaller BCEA area indicates more stable fixation. Fixation density is evaluated in the 2° and 4° areas according to the classification of G.Y. Fujii. Unsteady central fixation is defined when less than 75% of fixation points fall within the 2° area, and eccentric fixation is defined when the deviation of the fixation point from the center of the fovea is more than 2° [41,42,45].

It is recommended to perform ocular biomicroscopy (A03.26.001) in children with amblyopia in order to exclude other causes of visual acuity reduction [4,46,47].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to perform ophthalmoscopy (A02.26.003) of the central and peripheral fundus under conditions of mydriasis in children with amblyopia in order to exclude pathological changes of the retina and optic nerve that reduce visual acuity [4,46,48].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

It is recommended to perform an optical examination of the posterior segment of the eye using a computer analyzer (A03.26.019.002) in children with amblyopia for a morphometric assessment of internal eye structures, exclusion/detection of structural anomalies of the posterior pole of the eye, and confirmation/exclusion of the diagnosis of "amblyopia" [49,50].

Level of Evidence: 5Level of Recommendation C (Level of Evidence – 5)

Comments: devices for optical examination of the posterior segment of the eye are equipped with computer software that allows for image acquisition, database creation, and data storage. They provide a quantitative assessment of the status of retinal and optic nerve parameters in children with amblyopia.

It is recommended to perform electrophysiological studies (EPS): electroretinography (ERG) (A05.26.001) and visual evoked potentials (VEP) of the cerebral cortex (A05.26.002) in patients with amblyopia to determine the functional state of the eye and to confirm/exclude the diagnosis of amblyopia [1,4,5,51].

Level of Evidence: 5Level of Recommendation C (Level of Evidence – 5)

Comments: electroretinography (ERG) is a graphical representation of the electrical activity of the retina arising in response to light stimulation. ERG can be recorded from the entire retinal area (full-field or ganzfeld ERG) and from a local area of various sizes (macular ERG). ERG reflects the electrical activity of the majority of retinal cellular elements and depends on the number of healthy photoreceptors and neurons. Modern computer systems are used to record VEPs, allowing low-amplitude potentials to be isolated from noise by employing averaging and filters that neutralize various artifacts. The study is performed both while the child is awake and under sedation or general anesthesia. The main focus is on latency parameters. When analyzing the obtained data, it is taken into account that the formation of the VEP P1 wave is primarily influenced by the integrity of the retinocortical pathway, the maturity of the foveal region of the retina, and the integrity of the striate cortex. The method does not assess the integrity of the associative and cognitive functions of the brain that provide "visual recognition".

2.5 Other Procedures

Other diagnostic examinations are not used for amblyopia.

3. Treatment, including drug and non-drug therapies, diet therapy, and pain management

3.1 Optical correction

It is recommended to select spectacle correction for vision (A23.26.001) and/or contact lens correction for vision (A23.26.002) in children with amblyopia and concomitant ametropia in order to compensate for refractive and functional disorders [1,4,29,31,33,34,46,52].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

3.2 Functional treatment

It is recommended to stimulate the normal function of the retinal macula lutea (pleoptic treatment) (A16.26.110) using occlusion or penalization, local "blinding" flashes of the central fovea of the retina, the negative afterimage method, general flashes of the posterior pole of the retina using red light, frequency-contrast stimulation, laser pleoptics, localization methods, reflexology for visual organ diseases (A21.26.003), and other stimulation methods in children with amblyopia to improve visual acuity [1,2,3,4,7,9,33,44,46,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68].

Level of Evidence: 5Level of Recommendation C (Level of Evidence – 5)

Comments: one or more methods of pleoptic treatment are used to treat amblyopia.

It is recommended to perform treatment using microperimetric biofeedback (BFB) in children aged 5 years and older with amblyopia and eccentric unstable central fixation in order to establish central visual fixation, improve visual acuity, and increase retinal photosensitivity [41,42].

GCR BLeL 3Grade of Recommendation B (Level of Evidence – 3)

Comments: visual and acoustic BFB training is performed monocularly, under mesopic conditions, using a microperimeter and wireless headphones. A 2° training locus in the central zone of the macular area is selected for unstable central fixation, and 5° for eccentric fixation, and it is stimulated with a light pattern of 4° for unstable central fixation and 8° for eccentric fixation with maximum brightness and a flicker frequency of 20 Hz. The patient is provided with auditory motivation to fixate their gaze within the selected locus for 10–12 minutes, 3 times a week, for a total of 12–18 sessions [41,42].

3.3 Dietary therapy

Diet therapy is not used for amblyopia.

3.4 Pain Management

Pain management is not required in the treatment of amblyopia.

4. Medical Rehabilitation and Sanatorium-Resort Treatment

It is recommended for the rehabilitation of children with amblyopia to improve visual functions and visual performance: 1) timely prescription of optical correction corresponding to the refraction [1,3,4,9,29,33,46]; 2) implementation of pleoptic treatment [1,3,4,33,46,53,61,62,63,64,65,68]; 3) therapeutic and restorative measures in a kindergarten for children with amblyopia and strabismus [69,70]; 5) general health-improving measures [4,69].

GDR CLE 5Grade of recommendation C (level of evidence – 5)

Data on the efficacy, indications, and contraindications for sanatorium-resort treatment and the use of medical rehabilitation methods based on natural therapeutic factors in children with amblyopia are absent.

5. Prevention and Dispensary Observation

It is recommended to carry out a routine preventive examination (check-up, consultation) by an ophthalmologist (B04.029.002) in children to detect amblyopia, and to provide timely correction and treatment of functional disorders [1,3,4,9].

GCR CLEL 5Grade of Recommendation C (Level of Evidence – 5)

It is recommended to carry out a follow-up examination (check-up, consultation) by an ophthalmologist (B01.029.002) in children with amblyopia of any etiology every 3 months to assess disease dynamics, evaluate adaptation to optical correction (if prescribed), refine/change the correction (if prescribed), evaluate the efficacy of ongoing functional treatment, and determine further tactics of functional treatment [1,3,4,9,30,31,54,57].

CGR CLoE 5Level of Clinical Guidance Recommendation C (Level of Evidence – 5)

6. Organization of Medical Care

Medical care for amblyopia is provided on a scheduled basis.

Primary first-aid medical care for amblyopia is provided by medical personnel with secondary medical education; primary healthcare for amblyopia is provided by district pediatricians and general practitioners (family physicians). When amblyopia is suspected or detected, medical personnel with secondary medical education, district pediatricians, and general practitioners (family physicians) refer patients for a consultation with an ophthalmologist. For amblyopia, primary specialized healthcare is provided by an ophthalmologist.

In accordance with Order No. 211n dated April 14, 2025, "On approval of the procedure for minors undergoing preventive medical examinations, accounting form No. 030-PO/y 'Certificate of preventive medical examination of a minor', the procedure for maintaining it, as well as the form of sectoral statistical observation No. 030-PO/o 'Information on preventive medical examinations of minors', the procedure for filling it out during preventive medical examinations of minors, including upon admission to educational institutions and during the period of study in them," an ophthalmologist examines children at the ages of 1 month, 12 months, 3 years, 6 years, 7 years, 10 years, 13 years, 15 years, 16 years, and 17 years.

The ophthalmologist of the ophthalmology office provides: consultative, diagnostic, and therapeutic care; in the presence of medical indications, refers children to the pediatric vision conservation room or the pediatric ophthalmology department.

Medical care for children with amblyopia may (if outpatient treatment is impossible) be provided in a day or round-the-clock inpatient setting (at the discretion of the head of the pediatric ophthalmology department).

The indication for hospitalization is amblyopia requiring functional treatment that cannot be organized in an outpatient setting.

The indication for discharging a patient from a medical organization is the complete completion of the planned course of treatment.

7. Additional Information

When managing patients with amblyopia, the following factors must be considered: the child's age, previous diagnostic and therapeutic measures, and whether there is a positive effect from previous therapeutic measures. The special importance of timely diagnosis of amblyopia is also due to the fact that there is a certain "sensitive" period, up to 7–8 years [1,3,4,5], during which the maturation and formation of the visual pathway occur, and the visual prognosis in the child will depend on age, duration of visual deprivation, and the adequacy of the treatment performed during this period. Early examinations of children with mandatory determination of refraction and, if necessary, the prescription of corrective glasses and/or contact lenses are of decisive importance in amblyopia.

Given that amblyopia, especially of high and very high degrees, is often combined with a disturbance of the fixation mechanism, it is necessary to carry out diagnostic measures aimed at investigating fixation, assessing its localization and stability, and, depending on the diagnostic results, prescribing treatment for this category of patients [1,3,4,33,41,42].

Amblyopia is a functional disorder; any structural abnormalities of the visual analyzer exclude the diagnosis of "amblyopia". To confirm/exclude the diagnosis of "amblyopia", it is necessary to assess the structural and functional features of the visual analyzer (optical examination of the posterior segment of the eye using a computer analyzer, ERG, VEP) [1,4,49,50,51].

Criteria for Evaluating the Quality of Medical Care

№

Criteria for Evaluating the Quality of Medical Care

Medical services nomenclature code (if applicable)

Drug code in accordance with the ATC classification (if applicable)

Assessment of performance (Yes/No)

1

Initial appointment (examination, consultation) with an ophthalmologist was performed

B01.029.001

Not applicable

Yes/no

2

Visometry was performed without correction or in existing glasses or contact lenses in children with amblyopia (starting from the age when the child is able to name optotypes)

A02.26.004

Not applicable

Yes/no

3

Visometry was performed with optimal correction (starting from the age when the child is able to name optotypes)

A02.26.004

Not applicable

Yes/no

4

Refractometry performed

A03.26.008

Not applicable

Yes/no

5

Ophthalmoscopy was performed

A02.26.003

Not applicable

Yes/no

6

Selection of spectacle correction for vision and/or selection of contact lens correction for vision and/or stimulation of the normal function of the retinal macula lutea (pleoptic treatment) was performed

A23.26.001

A23.26.002

A16.26.110

Not applicable

Yes/no

References

Show references
  1. Avetisov E.S. Disbinocular amblyopia and its treatment / E.S. Avetisov. – M.: Meditsina, 1968. – 207 p.

  2. Zislina N.N. Neurophysiological mechanisms of visual perception disorders in children and adolescents / N.N. Zislina. – M.: Pedagogika, 1987. – 168 p.

  3. Avetisov E.S. Sodruzhestvennoe kosoglazie [Concomitant strabismus] / E.S. Avetisov. – M.: Meditsina, 1977. - 312 p.

  4. Rukovodstvo po detskoy ophtalmologii [Guide to pediatric ophthalmology] / ed. by E.S. Avetisov, E.I. Kovalevsky, A.V. Khvatova. – M.: Meditsina, 1987. – 495 p.

  5. Zislina N.N., Shamshinova A.M. Fiziologicheskie osnovy i vozmozhnosti ispolzovaniya zritelnykh vyzvannykh potentsialov v differentsialnoy diagnostike glaznykh bolezney [Physiological principles and potential use of visual evoked potentials in the differential diagnosis of eye diseases] // Klinicheskaya fiziologiya zreniya. Sbornik nauchnykh trudov. - M.: Rusomed, 1993. – P. 146–157.

  6. Von Noorden, G.K. Factors involved in the production of amblyopia // Br. J. Ophthalmol. – 1974. – Vol. 58, № 3. – P. 158–164.

  7. Avetisov E.S., Kashchenko T.P. Binokulyarnoe zrenie. Klinicheskie metody issledovaniya i vosstanovlenie [Binocular vision. Clinical research methods and rehabilitation] // Klinicheskaya fiziologiya zreniya. Sbornik nauchnykh trudov. – M.: Rusomed, 1993. – P. 199–209.

  8. Brutskaya L.A. Rol optiko-motorno-sensornykh mekhanizmov v razvitii ambliopii [The role of optic-motor-sensory mechanisms in the development of amblyopia] // Oftalmologiya. Vostochnaya Evropa. – 2012. – № 3. – P. 32–38.

  9. Kashchenko T.P. Problemy glazodvigatelnoy i binokulyarnoy patologii [Problems of oculomotor and binocular pathology] // Vestnik ophtalmologii. – 2006. – № 1. – P. 32–35.

  10. Chung S.T., Kumar G., Li R.W., Levi D.M. Characteristics of fixational eye movements in amblyopia: limitations on fixation stability and acuity?// Vision Res.- 2015.- Vol.114.-P. 87-99. DOI:10.1016/j.visres.2015.01.016. PMC4529398.

  11. Mansouri B., Stacy R.C., Kruger J., Cestari D.M. Deprivation amblyopia and congenital hereditary cataract // Semin. Ophthalmol. – 2013.- Vol. 28, № 5-6.- P. 321-326. DOI: 10.3109/08820538.2013.825289. PMID: 24138041.

  12. Kashchenko T.P., Kataev M.G., Sharipova S.K., Aklaeva N.A. Klinika, diagnostika i lechenie kosoglaziya, sochetannogo s ptozom [Clinical presentation, diagnosis, and treatment of strabismus combined with ptosis] // Vestnik ophtalmologii. – 2005. – № 2. – P. 8–11.

  13. Proskurina O.V., Kogoleva L.V., Bobrovskaya Yu.A. Tipichnyy sluchay chudesnogo izbavleniya ot slepoty [A typical case of miraculous recovery from blindness] // Rossiyskaya pediatricheskaya oftalmologiya. - 2024. - Vol. 19. - № 1. - P. 45-54. DOI:10.17816/rpoj623884

  14. Libman E.S., Shakhova E.V. Slepotota i invalidnost po zreniyu v Rossii [Blindness and visual disability in Russia] // VIII s"ezd oftalmologov Rossii: tezisy dokladov. – M.: MNTK "Mikrokhirurgiya glaza", 2005. – P. 78–79.

  15. Libman E.S., Shakhova E.V. Slepotota, slavovidenie i invalidnost po zreniyu v Rossiyskoy Federatsii [Blindness, low vision, and visual disability in the Russian Federation] // Likvidatsiya ustranimoy slepoty. Vsemirnaya initsiativa VOZ. Materialy Rossiyskogo mezhregionalnogo simpoziuma. – Ufa, 2003. – P. 21–25.

  16. Faghihi M., Ostadimoghaddam H., Yekta A.A. Amblyopia and strabismus in Iranian schoolchildren, Mashhad // Strabismus. – 2011.- Vol.19,№ 4.- P.147-152. DOI: 10.3109/09273972.2011.622341.

  17. Eibschitz-Tsimhoni M., Friedman T., Naor J., Eibschitz N., Friedman Z. Early screening for amblyogenic risk factors lowers the prevalence and severity of amblyopia // J. AAPOS.- 2000.- Vol.4, № 4.- P.194-199. DOI: 10.1067/mpa.2000.105274

  18. Dikova S.P., Dragoev S.A., Chernodrinska V.S. Prevalence of amblyopia in Bulgaria // Strabismus. – 2018.- Vol.26, № 4.- P.163-167. DOI: 10.1080/09273972.2018.1530266

  19. Donnelly U.M., Stewart N.M., Hollinger M. Prevalence and outcomes of childhood visual disorders // Ophthalmic Epidemiol.- 2005.- Vol.12,№ 4.- P. 243-50. DOI:10.1080/09286580590967772.

  20. Risk factors for strabismus and amblyopia in young Singapore Chinese children / A. Chia, X. Lin, M.D irani, G. Gazzard, D. Ramamurthy, B.L. Quah, B. Chang, Y. Ling, S.W. Leo, T.Y. Wong, S.M. Saw // Ophthalmic Epidemiol. -2013.- Vol. 20,№3.- P.138-147. DOI:10.3109/09286586.2013.767354.

  21. Global and regional estimates of prevalence of amblyopia: A systematic review and meta-analysis / H. Hashemi, R. Pakzad MSc, A. Yekta, P. Bostamzad, M. Aghamirsalim, S. Sardari MSc, M. Valadkhan MSc, M. Pakbin MSc, S. Heydarian, M. Khabazkhoob // Strabismus. – 2018.- Vol.26,№ 4.-P. 168-183. DOI: 10.1080/09273972.2018.1500618.

  22. Global prevalence of amblyopia and disease burden projections through 2040: a systematic review and meta-analysis / Z. Fu, H. Hong, Z. Su, B. Lou, C.W. Pan, H. Liu // Br. J. Ophthalmol. – 2020.- Vol.104, № 8.- P.1164-1170. DOI: 10.1136/bjophthalmol-2019-314759.

  23. Katargina L.A., Mikhaylova L.A. Sostoyanie detskoy ophtalmologicheskoy sluzhby v Rossiyskoy federatsii (2012-2013 gg.) [State of the pediatric ophthalmology service in the Russian Federation (2012-2013)] // Rossiyskaya pediatricheskaya oftalmologiya. – 2015. – Vol. 10, № 1. – P. 5–10.

  24. Neroev V.V. Organizatsiya ophtalmologicheskoy pomoshchi naseleniyu Rossiyskoy Federatsii [Organization of ophthalmological care for the population of the Russian Federation] // Vestnik ophtalmologii. – 2014. – Vol. 30, № 6. – P. 8–12.

  25. Neroev V.V., Katargina L.A., Kogoleva L.V. Profilaktika slepoty i slavovideniya u detey s retinopatiey nedonoshennykh [Prevention of blindness and low vision in children with retinopathy of prematurity] // Voprosy sovremennoy pediatrii. – 2015. – № 2. – P. 265–270.

  26. Brutskaya L.A. K voprosu pleopticheskogo lecheniya [On the issue of pleoptic treatment] // Oftalmologiya. Vostochnaya Evropa. – 2012. – № 3. – P. 76–82.

  27. Okovitov V.V. Metody fizioterapii v oftalmologii [Physiotherapy methods in ophthalmology] / V.V. Okovitov.- M.:TsVNIAG, 1999. - 158 p.

  28. Avetisov S.E., Sheludchenko V.M., Kamenskikh T.G. Fizioterapevticheskie metody [Physiotherapeutic methods] // Oftalmologiya. Natsionalnoe rukovodstvo. / ed. by S.E. Avetisov, E.A. Egorov, L.K. Moshetova, V.V. Neroev, H.P. Takhchidi.- M.: Geotar-Media, 2024. – P. 217-231.

  29. Rosenblum Yu.Z., Proskurina O.V. Ostrota zreniya, refraktsiya i akkomodatsiya u detey [Visual acuity, refraction, and accommodation in children] // Zritelnye funktsii i ikh korrektsiya u detey / ed. by S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova.- M.:Meditsina, 2005.-P.38-65.

  30. Reshetova P.S., Semenov P.A., Soboleva I.I. Vliyanie stressa na snizhenie zreniya [The effect of stress on vision reduction] // Vestnik Soveta molodykh uchenykh i spetsialistov Chelyabinskoy oblasti. - 2016. – Vol.4, № 3(14). - P. 78-82. URL: https://cyberleninka.ru/article/n/vliyanie-stressa-na-snizhenie-zreniya

  31. Rukovodstvo po meditsinskoy optike. Chast 1. Osnovy optopometrii [Guide to medical optics. Part 1. Fundamentals of optometry] / ed. by A.V. Myagkov, N.P. Parfenova, E.I. Demina.- M.: Aprel, 2016.- 205 p.

  32. Rosner J. Pediatric optometry/J. Rosner.-Boston,London: Butterworths, 1982.- P.36-67.

  33. Plisov I.L. Ambliopiya: Metody diagnostiki i lecheniya. Prakticheskie sovety [Amblyopia: Diagnostic and treatment methods. Practical advice] // Mir oftalmologii. - 2011. - № 2. - P. 4.

  34. Rosenblum Yu.Z. Optometriya [Optometry] / Yu.Z. Rosenblum.- S.Pb.: Hippocrates, 1996.- 247 p.

  35. Rosenblum Yu.Z., Proskurina O.V. Primenenie avtomaticheskikh refraktometrov v praktike vracha oftalmologa i optometrista [Use of automatic refractometers in the practice of ophthalmologists and optometrists] // Vestn. optometrii.- 2001.- № 5.- P. 9-17.

  36. Plisov I.L., Kudryashova L.V., Belousova K.A., Bikbulatova D.R. Binokulyarnyy refraktometr Plusoptix: prakticheskiy opyt primeneniya v optometrii i strabizmologii // Materialy yubileynoy nauchnoy konferentsii "Nevskie gorizonty". – 2010.- Vol. 2.– SPb., 2010. – P. 233-245

  37. Proskurina O.V. Staticheskaya i dinamicheskaya retinoskopiya (skiaskopiya) [Static and dynamic retinoscopy (skiascopy)] // Vestnik optometrii. – 2012.- № 5.- P. 44-46.

  38. Systematic review and meta-analysis on the agreement of non-cycloplegic and cycloplegic refraction in children / S. Wilson, I. Ctori, R. Shah, C. Suttle, M.L. Conway // Ophthalmic Physiol Opt.-2022.- Vol.42,№ 6.- P.1276-1288. DOI: 10.1111/opo.13022.

  39. Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis / N. Yazdani, R. Sadeghi, H. Momeni-Moghaddam, L. Zarifmahmoudi, A. Ehsaei // J. Optom. – 2017. - Vol.11,№ 3. P.135-143.  DOI: 10.1016/j.optom.2017.09.001.

  40. Proskurina O.V. Cycloplegic efficacy of cyclopentolate and tropicamide preparations compared to atropinization // Vestnik Oftalmologii. - 2002. - No. 6. - P. 45-48.

  41. Vzaimosvyaz parametrov zritelnoy fiksatsii, svetochuvstvitelnosti setchatki i ostroty zreniya pri razlichnykh vidakh ambliopii [Correlation of visual fixation parameters, retinal light sensitivity, and visual acuity in various types of amblyopia] / E.P. Tarutta, R.R. Khubieva, A.V. Apaev, S.V. Milash, G.A. Markosyan // Vestnik ophtalmologii. -2021.- Vol.137,№ 3.- P.32-38. DOI: 10.17116/oftalma202113703132.

  42. Novyy metod lecheniya ambliopii u detey s neustoychivoy tsentralnoy i netsentralnoy fiksatsiey s pomoshchyu biologicheskoy obratnoy svyazi [A new method for treating amblyopia in children with unstable central and eccentric fixation using biofeedback] / E.P. Tarutta, R.R. Khubieva, S.V. Milash, A.V. Apaev, N.A. Aklaeva, I.V. Zolnikova // Rossiyskiy oftalmologicheskiy zhurnal. – 2022.- Vol.15,№ 2.- P.109-119. DOI:10.21516/2072-0076-2022-15-2-109-119

  43. Robb R.M. Modification of may ophthalmoscope: for the determination of monocular fixation // Am. J. Ophthalmol. -1966.- Vol. 62, № 1.- P.164-165. DOI: 10.1016/0002-9394(66)91703-x. PMID: 5937154.

  44. Narusheniya binokulyarnogo zreniya. Uchebnoe posobie dlya studentov vrachebnykh fakultetov [Disorders of binocular vision. Study guide for medical students] / ed. by O.I. Krivosheina, I.V. Zapuskalov, A.A. Fetisov. - Tomsk, 2008.- 37 p.

  45. Patient selection for macular translocation surgery using the scanning laser ophthalmoscope / G. Y. Fujii, E.de Juan Jr, J. Sunness, M.S. Humayun, D.J. Pieramici, T.S. Chang // Ophthalmology. – 2002.- Vol.109,№ 9.- P.1737-1744.  DOI:10.1016/s0161-6420(02)01120-x.

  46. Glaznye bolezni [Eye diseases] / ed. by V.G. Kopaeva.- M.:Meditsina, 2008.- 560 p. 39.

  47. Alekseev V.N., Gazizova I.R. Biomicroscopiya [Biomicroscopy] // Oftalmologiya. Natsionalnoe rukovodstvo / ed. by S.E. Avetisov, E.A. Egorov, L.K. Moshetova, V.V. Neroev, H.P. Takhchidi.- M.: Geotar-Media, 2024. – P. 37-47.

  48. Egorov E.A., Rabadanova M.G. Oftalmoskopiya [Ophthalmoscopy] // Oftalmologiya. Natsionalnoe rukovodstvo / ed. by S.E. Avetisov, E.A. Egorov, L.K. Moshetova, V.V. Neroev, H.P. Takhchidi.- M.: Geotar-Media, 2024. – P. 78-87.

  49. Sokolov V.A., Al-Sharafi A.A.Kh. Opticheskaya kogerentnaya tomografiya v diagnostike ambliopii u detey (obzor literatury) [Optical coherence tomography in the diagnosis of amblyopia in children (literature review)] // Ros. med.-biol. vestn. im. akad. I.P. Pavlova. - 2012. – Vol. 20,№ 4.- P.170-173.

  50. Khubieva R.R., Tarutta E.P. Sovremennye metody diagnostiki morfofunktsionalnykh osobennostey setchatki pri disbinokulyarnoy i anizometropicheskoy ambliopii [Modern methods for diagnosing morphofunctional characteristics of the retina in strabismic and anisometropic amblyopia] //Oftalmologiya. – 2022. – Vol. 19. – №. 1. – P. 63-70.

  51. Funktsionalnye metody issledovaniya v oftalmologii [Functional research methods in ophthalmology] / ed. by A.M. Shamshinova, V.V. Volkov. — M. : Meditsina, 1998. — 415 p.

  52. Rosenblum Yu.Z. Funktsionalno-vozrastnoy podkhod k kompensatsii ametropii [Functional and age-related approach to the compensation of ametropia] // Vestn. ophtalmol. -2004.-Vol.120, № 1.- P. 51-56.

  53. Khvatova N.V., Slyshalova N.N. Lechenie ambliopii i tendentsii ego razvitiya. Obzor literatury [Treatment of amblyopia and trends in its development. Literature review] // Oftalmokhirurgiya i terapiya. - 2002. - № 3-4(2). - P. 27-34.

  54. Campbell F.W., Hess R.F., Watson P.G., Banks R. Preliminary results of a physiologically based treatment of amblyopia // Br. J. Ophthalmol. – 1978.- Vol.62,№ 11.- P.748-755 DOI:10.1136/bjo.62.11.748. 22.

  55. Kuruca S., Niyaz L., Yucel O.E., Erkan N.D. Results of CAM therapy in amblyopic patients // Vestnik ophtalmologii.- 2015.- Vol. 131, № 4.- P. 83-87. DOI: 10.17116/oftalma2015131483-86. PMID: 26489125.

  56. Bangerter A. Amblyopia therapy // Bibl. Ophthalmol. – 1953.- Vol.112,№ 37.- P.1-96.

  57. McConaghy J.R., McGuirk R. Amblyopia: detection and treatment // Am. Fam. Physician. – 2019.- Vol. 100,№ 12.-P.745-750.

  58. Ambliopiya: etiopatogenez, diagnostika, strategii lecheniya: prakticheskoe posobie dlya vrachey [Amblyopia: etiopathogenesis, diagnosis, treatment strategies: practical guide for physicians] / ed. by Yu.I. Rozhko, A.V. Yanochkin, A.A. Rozhko. – Gomel: State Institution "RNPTs RMiECH", 2021.– 48 p.

  59. Kukuyuk T.V., Gromakina E.V. Effektivnost medikamentoznoy penalizatsii pri lechenii ambliopiya u detey [Efficacy of pharmacological penalization in the treatment of amblyopia in children] // Vostok – Zapad. Tochka zreniya. Razdel VII. Detskaya ophtalmopatologiya. - 2014. - № 1.

  60. Pediatric eye disease investigator group. A randomized trial of atropine vs. patching for treatment of moderate amblyopia in children // Arch. Ophthalmol.- 2002.- Vol.120,№ 3.- P.268-278. DOI: 10.1001/archopht.120.3.268. PMID: 11879129.

  61. Kashchenko T.P., Yachmeneva E.I. Sodruzhestvennoe kosoglazie: patogenez, klinika, metody issledovaniya i vosstanovleniya zritelnykh funktsiy [Concomitant strabismus: pathogenesis, clinical presentation, research methods, and rehabilitation of visual functions] // Zritelnye funktsii i ikh korrektsiya u detey / ed. by S.E. Avetisov, T.P. Kashchenko, A.M. Shamshinova.- M.:Meditsina, 2005.- P. 66-92.

  62. Matrosova Yu.V., Fabrikantov O.L. Funktsionalnye rezultaty pleopticheskogo lecheniya ambliopii s ispolzovaniem lazernykh speklov krasnogo i zelenogo diapazonov [Functional results of pleoptic treatment of amblyopia using red and green laser speckles] // Vestnik rossiyskikh universitetov. Matematika. - 2017. –Vol.22,№ 4.- P. 682-686. URL: https://cyberleninka.ru/article/n/funktsionalnye-rezultaty-pleopticheskogo-lecheniya-ambliopii-s-ispolzovaniem-lazernyh-speklov-krasnogo-i-zelenogo-diapazonov.

  63. Matrosova Yu.V., Fabrikantov O.L. Lazernye spekly v lechenii anizometropicheskoy ambliopii [Laser speckles in the treatment of anisometropic amblyopia] // Oftalmologiya.- 2018.- Vol.15,№ 2S.- P. 52-57. DOI:10.18008/1816-5095-2018-2S-52-57

  64. Novitskaya V.A., Karyakina O.E., Karyakin A.A., Orudzhova O.N. Computer program for the restoration of visual functions in children with amblyopia. // Modern High Technologies. – 2022. – No. 4. – P. 68-73. DOI: 10.17513/snt.39110

  65. Lavrentiev B.F., Rozhentsov V.V. Hardware means for the treatment of amblyopia. // Ophthalmology. – 2016. – Vol. 13, No. 3. – P. 144-150. DOI: 10.18008/1816-5095-2016-3-144-150.

  66. Malinovskaya T.A., Ivanov A.N., Bolotova L.O., Tarakanovsky A.V., Chuvilina M.V. Treatment of patients with oculomotor disorders using traditional medicine and physiotherapy methods. // Traditional Medicine. – 2016. – Vol. 47, No. 4. – P. 4-12.

  67. Pasmanik E.F., Nizovtseva T.R. On the complex treatment of amblyopia using reflexology and traditional pleoptics methods. // Bulletin of Ophthalmology. – 1993. – No. 4. – P. 6-8.

  68. Lukoshina M.K., Myagkikh A.I. Results of visual acuity restoration in children using the "Amblyocor" device. // The EYE. – 2017. – Vol. 19, No. 3(118). – P. 29-31.

  69. Grigoryan L.A. Therapeutic and rehabilitation work in kindergartens for children with amblyopia and strabismus. // Teaching and Upbringing of Preschoolers with Visual Impairments / ed. by M.I. Zemtsova. – M.: Prosveshchenie, 1978. – P. 24-41.

  70. Kerpal I., Bredenfeld M. Correction of amblyopia and strabismus in children in a kindergarten setting. // Teaching and Upbringing of Preschoolers with Visual Impairments / ed. by M.I. Zemtsova. – M.: Prosveshchenie, 1978. – P. 44-47.

Appendix A1. Working Group Composition

  1. Apaev Alexander Vyacheslavovich, Candidate of Medical Sciences, Association of Ophthalmologists LLC.

  2. Aklaeva Naila Anvarovna, Candidate of Medical Sciences, Association of Ophthalmologists LLC.

  3. Zhukova Olga Vladimirovna, Doctor of Medical Sciences, Association of Ophthalmologists LLC.

  4. Proskurina Olga Vladimirovna, Doctor of Medical Sciences, Association of Ophthalmologists LLC.

  5. Stalmakhova Regina Rasulovna, Candidate of Medical Sciences, Association of Ophthalmologists LLC.

  6. Tarutta Elena Petrovna, Group Head, Dr. of Med. Sci., Professor, Association of Ophthalmologists LLC.

No conflict of interest is declared.

Appendix A2. Methodology for Developing Clinical Guidelines

Methods used for collecting/selecting evidence: search in electronic databases; analysis of modern scientific developments on the problem of amblyopia in Russia and abroad; synthesis of practical experience of Russian and foreign colleagues.

When selecting publications as potential sources of evidence, the methodology used in each study is examined to ensure its reliability. The result of this examination affects the level of evidence assigned to the publication, which in turn affects the strength of the recommendations derived from it.

A preliminary version of these guidelines was reviewed by independent experts who were asked to comment primarily on whether the interpretation of the evidence underlying the recommendations is reliable and accessible to practicing physicians and patients.

Comments were received from ophthalmologists specializing in amblyopia and primary care physicians regarding the clarity of presentation and the importance of recommendations as a working tool in daily medical practice.

Comments received from experts were carefully systematized and discussed by the chairs and members of the working group. Every item was discussed. Changes and additions recommended as a result of the discussion were incorporated into the text of the guidelines.

Target audience for these clinical guidelines:

  1. Ophthalmologists;

  2. General practitioners (family physicians);

  3. Pediatricians;

  4. District pediatricians.

Table 1. Scale for assessing levels of evidence (LE) for diagnostic methods (diagnostic interventions)

LoE

Definition

1

Systematic reviews of studies with reference standard control or systematic reviews of randomized controlled trials with meta-analysis

2

Individual studies with reference standard control or individual randomized controlled trials and systematic reviews of studies of any design, except randomized controlled trials, with meta-analysis

3

Studies without consecutive reference standard control or studies with a reference standard not independent of the test method, or non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case report

5

Only justification of mechanism of action or expert opinion is available

Table 2. Scale for assessing levels of evidence (LoE) for prevention, treatment, and rehabilitation methods, including those based on natural therapeutic factors (preventive, therapeutic, and rehabilitation interventions)

LoE

Definition

1

Systematic review of RCTs with meta-analysis

2

Individual RCTs and systematic reviews of studies of any design except RCTs, with meta-analysis

3

Non-randomized comparative studies, including cohort studies

4

Non-comparative studies, case reports or case series, case-control studies

5

Only justification of the mechanism of action of the intervention (preclinical studies) or expert opinion is available

Table 3. Scale for assessing grades of recommendation (GoR) for prevention, diagnostic, treatment, and rehabilitation methods (preventive, diagnostic, therapeutic, and rehabilitation interventions, including those based on natural therapeutic factors)

GoR

Definition

A

Strong recommendation (all considered efficacy criteria (outcomes) are important, all studies are of high or acceptable methodological quality, and their conclusions on the outcomes of interest are consistent)

B

Conditional recommendation (not all considered efficacy criteria (outcomes) are important, not all studies are of high or acceptable methodological quality, and/or their conclusions on the outcomes of interest are inconsistent)

C

Weak recommendation (lack of adequate quality evidence (all considered efficacy criteria (outcomes) are unimportant, all studies are of low methodological quality, and their conclusions on the outcomes of interest are inconsistent)

Procedure for updating clinical guidelines.

The mechanism for updating clinical guidelines provides for their systematic revision at least once every three years, as well as upon the emergence of new evidence-based medicine data on the diagnosis, treatment, prevention, and rehabilitation of specific diseases, or in the presence of justified additions/comments to previously approved clinical guidelines, but no more frequently than once every 6 months.

Appendix A3. Reference Materials

These clinical guidelines were developed taking into account the following regulatory legal documents:

  1. Order of the Russian Ministry of Health No. 614n dated October 9, 2025, "On Approval of the Procedure for Providing Medical Care to Children in the Profile 'Ophthalmology'."

  2. Order of the Russian Ministry of Health No. 203n dated April 14, 2025, "On Approval of Criteria for Assessing the Quality of Medical Care."

  3. Order of the Russian Ministry of Health No. 211n dated April 14, 2025, "On Approval of the Procedure for Minors Undergoing Preventive Medical Examinations, Accounting Form No. 030-PO/u 'Minor's Preventive Medical Examination Card', the Procedure for Its Maintenance, as Well as Industry Statistical Observation Form No. 030-PO/o 'Information on Preventive Medical Examinations of Minors', and the Procedure for Its Completion."

  4. Directive of the Government of the Russian Federation No. 3867-r dated December 18, 2025.

  5. State Register of Medicines (as of April 1, 2026).

Table. Drugs used for refraction determination in amblyopia

INN, ATC code

Route of administration

Doses

Cyclopentolate 1% eye drops, S01FA04

Into the conjunctival sac

1-2 drops, 2-3 times at intervals of 15-15 minutes [38,39,40]

Atropine** 1% eye drops, S01FA01

Into the conjunctival sac

1-2 drops 2 times a day for 3 days [4,29]

Appendix B. Physician Action Algorithms

Appendix B. Physician Action Algorithms — Amblyopia

Appendix C. Patient Information

Despite the diversity of visual physiology parameters, central vision is rightfully recognized as the main function of the organ. Upon its reduction or loss, a person loses the capacity for professional and practical activity, which leads to both a sharp decrease in quality of life and social maladjustment. Amblyopia is a pathology in which the decrease in central visual acuity is accompanied by impaired visual fixation, color, contrast, light, and electrical sensitivity. By its nature, amblyopia is a type of functional pathology of the higher divisions of the central nervous system, the pathophysiological basis of which is persistent cortical inhibition of the central vision function, developed as a consequence of sensory deprivation in early childhood. Such a condition as amblyopia reduces a child's quality of life; in high degrees, it leads to disability and a sharp restriction of future professional choice.

In amblyopia, it is very important to conduct diagnostic measures to exclude any other eye pathology and confirm the diagnosis of "amblyopia." Currently, modern diagnostics are oriented toward minimally invasive, fast, and, most importantly, safe devices that allow the study of the visual analyzer in pediatric patients.

Despite the large number of methods used for treating amblyopia, desired functional results are not always achieved after treatment, which, in turn, may be associated with diagnostic errors. It is necessary to diagnose the key pathogenetic link of amblyopia and chart a treatment vector taking into account the obtained data. It is worth remembering that high and very high degrees of amblyopia are often associated with impaired fixation mechanisms.

Thus, of decisive importance for children with amblyopia are correct diagnosis, timely detection of ametropia in a child and the prescription of adequate optical correction in early childhood; parental control and compliance with the pleoptic treatment regimen, and functional hardware treatment.

Appendix G. Assessment Scales, Questionnaires, and Other Evaluation Tools

Not used.

ClinRevs Pro690 ₽ per month · cancel anytime

Clinical calculators and scalesRisk calculation, dosing, and scoring using scales from clinical guidelines — online, no registration required.

Open calculators

Answers based on Russian clinical guidelines directly in ChatGPT and Claude Connect the WhiteCoat Pro connector, and the assistant will answer based on the "Amblyopia" guideline and other active MoH clinical guidelines with a reference to the section rather than retelling foreign guidelines. Address: mcp.pervoklassno.ru/mcp. How to configure ChatGPT, Claude, Gemini, and Perplexity for Russian clinical guidelines

Subscribe in 2 minutes

AI Research DigestEvery morning — fresh PubMed articles in your specialty: translation, AI analysis, and link to the original. Reads in four minutes.

Subscribe for 990 ₽

Related clinical guidelines